In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018, Harvard Medical School
Credit: CC0 Public Domain

The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. Most clinical efforts have focused on minimizing risk through dosage management, but a new study led by investigators at Harvard Medical School suggests that the dose may not always make the poison.

The findings, to be published Jan. 20 in BMJ, show that among surgery patients with no history of recent or chronic use how long a person takes the drugs for is a more potent predictor of abuse and overdose than how much medication a patient takes. Dosage, however, emerged as a powerful risk indicator among those who took the medications for extended periods, the research found.

The study—based on analysis of more than a half million records of privately insured patients who received opioids after surgery between 2008 and 2016—represents the largest effort to date to quantify following surgery.

The findings provide much-needed insight and nuance into the complex dynamic that may fuel opioid misuse, the researchers said. The results, they added, could help inform field-specific guidelines for a medical specialty that, more than any other, relies on opioid pain management. Indeed, research shows that surgery patients are four times more likely than other patients to receive opioids.

"We are in the midst of an epidemic, and physician prescription practices play no small part in it," said study senior investigator Nathan Palmer, a biomedical informatics researcher at Harvard Medical School. "Understanding differences in risk for opioid misuse across various patient populations and clinical contexts is critical in informing the creation of narrowly tailored guidelines, clinical decision making and the national conversation on this topic."

The findings highlight the need to pay particular attention to the duration of treatment and the number of refills, the team said, and also suggest that surgeons should be swift to refer patients to chronic pain specialists for symptom management if their discomfort persists.

"As surgeons, we often struggle to balance the risk of abuse with our duty to manage pain, but our findings underscore how potent a single stroke of the pen can be in fueling this risk," said study co-first author Gabriel Brat, instructor in surgery and in at Harvard Medical School and a trauma surgeon at Beth Israel Deaconess Medical Center.

"Our results indicate that each additional week of medication use, every refill is an important maker of risk for abuse or dependence"," said co-first author Denis Agniel, a statistician at the RAND Corporation and a part-time lecturer in the Department of Biomedical Informatics at Harvard Medical School.

Over the past 15 years, the rates of in the United States have tripled. Opioid overdoses now rank as a leading cause of nonintentional death, and most of these deaths can be traced back to an initial prescription opioid. Previous research suggests that between 3 percent and 10 percent of patients who receive opioids for the first time go on to become chronic users.

In the new study, none of the 560,000 patients had a record of chronic or extended opioid use leading up to surgery. For the purposes of the research, patients were deemed non- opioid users if they had not taken opioids in the two months prior to their surgery, or if they had used opioids for fewer than seven days prior to their procedure.

Of the more than half million patients, 0.6 percent, or 5,906, developed dependence, symptoms of abuse or experienced a nonfatal overdose—collectively defined as opioid misuse. A third of the misuse diagnoses occurred within a year of the surgery. Each additional week of opioid use increased the risk for dependence, abuse or overdose by 20 percent. Each additional refill boosted the risk by 44 percent, the analysis showed, with the first refill more than doubling the risk. To calculate the risk, researchers measured the number of abuse, overdose and dependence cases against the total number of combined years patients were followed, a common statistical method for gauging risk. Among those who had a single prescription with no refills, misuse occurred at a rate of 145 cases per 100,000 patient years, compared with 293 per 100,000 among those who had a single refill following the original prescription.

By contrast, dosage—the amount of medication a patient takes over 24 hours—played a far smaller role, the analysis showed. In fact, the researchers noted, among people taking opioids for short periods—two weeks or less—the risk for misuse was no greater even among on dosages that were twice as high. However, higher dosage did propel risk significantly among those taking opioids for nine weeks or longer, a finding that suggests a potent confluence of duration and dosage among long-term users, the team said.

Current guidelines on opioid pain management are generic and do not address specific patient populations. The new findings, however, suggest that clinical context matters, and that opioid decision making should vary with the context.

"As physicians, we face a dilemma with each opioid prescription, so we need a more nuanced understanding of how to weigh the risks and benefits of opioid pain management immediately after surgery, including factors that influence misuse," said Isaac Kohane, co-senior author on the study and head of the Department of Biomedical Informatics at Harvard Medical School. "These results provide much-needed clarity."

Explore further: Risk of persistent opioid use a concern for youth after surgery

More information: Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study, BMJ (2018). www.bmj.com/content/360/bmj.j5790

Related Stories

Risk of persistent opioid use a concern for youth after surgery

December 4, 2017
(HealthDay)—Adolescents and young adults are at risk for persistent opioid use after surgery, and this represents an important pathway to consider in the epidemic of prescription opioid misuse, according to a study published ...

Plastic surgeons get tips on managing opioid addiction risk

October 2, 2017
Opioid medications prescribed for pain management after plastic surgery may contribute to the ongoing opioid epidemic, according to a special topic paper in the October issue of Plastic and Reconstructive Surgery, the official ...

Doctors prescribing too many opioids after nose jobs

November 9, 2017
(HealthDay)—Could some patients recovering from a nose job get a problem they didn't bargain for?

CDC launches opioid campaign in hard-hit states

September 26, 2017
(HealthDay)—The U. S. Centers for Disease Control and Prevention has launched a campaign to reduce overdose deaths from prescription opioid painkillers.

Gabapentin co-use may increase risk of fatal opioid overdose

October 3, 2017
Co-prescription of the anticonvulsant gabapentin is associated with an increased risk of opioid-related death in people who are prescribed opioid painkillers, according to a new study published in PLOS Medicine.

Bulk of opioid use in the U.S. concentrated among 10 percent of patients

September 11, 2017
A small proportion (10 percent) of opioid users account for the vast majority of opioid use in the United States. These findings suggest that efforts to reduce prescription opioid abuse should focus on the top users, rather ...

Recommended for you

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

Reclassification recommendations for drug in 'magic mushrooms'

September 26, 2018
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

New study finds concurrent use of prescription drugs and dietary supplements could pose health risks

September 25, 2018
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.